We are live on ! Find out more
CA

Callahan Advisors Portfolio holdings

AUM $1.33B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+2.61%
1 Year Est. Return
+29.71%
3 Year Est. Return
+87.75%
5 Year Est. Return
+121.89%
10 Year Est. Return
+408.77%
AUM
$381M
AUM Growth
+$15.9M
Cap. Flow
+$9.58M
Cap. Flow %
2.51%
Top 10 Hldgs %
26.63%
Holding
120
New
6
Increased
70
Reduced
23
Closed
5

Top Sells

Rank Stock Value
1
CNI icon
Canadian National Railway
CNI
+$882K
2
CVS icon
CVS Health
CVS
+$739K
3
JWN
Nordstrom
JWN
+$560K
4
STE icon
Steris
STE
+$349K
5
FISV
Fiserv Inc
FISV
+$341K

Sector Composition

Rank Sector Weight
1 Technology 16.68%
2 Healthcare 16.19%
3 Financials 13.05%
4 Consumer Staples 10.15%
5 Consumer Discretionary 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
1
ExxonMobil
XOM
$643B
$12.1M 3.19%
129,517
+1,512
+1% +$134K
SCHO icon
2
Schwab Short-Term US Treasury ETF
SCHO
$12.8B
$11.9M 3.13%
468,198
+48,212
+11% +$1.22M
JNJ icon
3
Johnson & Johnson
JNJ
$613B
$11.3M 2.97%
93,322
-262
-0.3% -$29.8K
AAPL icon
4
Apple
AAPL
$4.46T
$11.1M 2.91%
462,980
+32,532
+8% +$808K
GE icon
5
GE Aerospace
GE
$383B
$10M 2.63%
66,463
+1,614
+2% +$235K
T icon
6
AT&T
T
$162B
$9.43M 2.48%
289,004
+11,938
+4% +$355K
MCD icon
7
McDonald's
MCD
$188B
$9.26M 2.43%
76,943
-1,595
-2% -$200K
INTC icon
8
Intel
INTC
$459B
$8.8M 2.31%
268,401
+5,966
+2% +$187K
UNH icon
9
UnitedHealth
UNH
$377B
$8.71M 2.29%
61,678
-1,376
-2% -$183K
PFE icon
10
Pfizer
PFE
$143B
$8.69M 2.28%
260,242
+138
+0.1% +$4.4K
MSFT icon
11
Microsoft
MSFT
$3.62T
$8.67M 2.28%
169,473
+2,972
+2% +$154K
JPM icon
12
JPMorgan Chase
JPM
$937B
$8.35M 2.19%
134,429
+1,261
+0.9% +$78.8K
PG icon
13
Procter & Gamble
PG
$338B
$8.24M 2.16%
97,326
+3,183
+3% +$261K
GOOG icon
14
Alphabet (Google) Class C
GOOG
$4.56T
$7.96M 2.09%
229,920
+14,860
+7% +$534K
PEP icon
15
PepsiCo
PEP
$191B
$7.88M 2.07%
74,404
+563
+0.8% +$58.1K
NKE icon
16
Nike
NKE
$63.3B
$7.8M 2.05%
141,287
+67
+0% +$3.82K
CB icon
17
Chubb
CB
$134B
$7.66M 2.01%
58,584
+219
+0.4% +$27K
GILD icon
18
Gilead Sciences
GILD
$163B
$7.64M 2.01%
91,542
+768
+0.8% +$68.2K
NEE icon
19
NextEra Energy
NEE
$181B
$7.58M 1.99%
232,664
+2,348
+1% +$70.5K
PAYX icon
20
Paychex
PAYX
$41.9B
$7.49M 1.97%
125,911
+4,168
+3% +$223K
WFC icon
21
Wells Fargo
WFC
$266B
$7.47M 1.96%
157,820
+6,517
+4% +$318K
DIS icon
22
Walt Disney
DIS
$170B
$7.4M 1.94%
75,658
+1,662
+2% +$166K
CSCO icon
23
Cisco
CSCO
$457B
$7.4M 1.94%
257,933
+6,197
+2% +$174K
BN icon
24
Brookfield
BN
$107B
$7.37M 1.94%
624,412
-2,140
-0.3% -$25.6K
BRK.B icon
25
Berkshire Hathaway Class B
BRK.B
$1.11T
$6.74M 1.77%
46,565
+1,065
+2% +$152K

Similar funds

Callahan Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, Callahan Advisors held 120 positions worth $381M, up 4.4% from $365M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Callahan Advisors's Q2 2016 filing shows 6 new, 70 increased, 23 reduced and 5 closed positions. Its largest new stake was Royal Dutch Shell PLC ADS Class B: 6,850 shares worth $384K. The largest sale was Canadian National Railway, an estimated $882K.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • Callahan Advisors's largest Q2 2016 buy was Royal Dutch Shell PLC ADS Class B: 6,850 shares worth $384K.
  • Callahan Advisors added most to Dycom Industries in Q2 2016, an estimated $1.53M increase.
  • Callahan Advisors's biggest Q2 2016 reduction was CVS Health, cutting an estimated $739K.
  • Callahan Advisors fully exited Canadian National Railway in Q2 2016, selling an estimated $882K.
  • Callahan Advisors's ten largest holdings make up 27% of its $381M portfolio in Q2 2016.
  • Callahan Advisors opened 6 new positions and closed 5 in Q2 2016.
  • Callahan Advisors's portfolio value rose 4.4% quarter-over-quarter to $381M.

Based on Callahan Advisors's 13F filing for Q2 2016, filed 25 Jul 2016.